KALARIS THERAPEUTICS INC

Q2 2026 13F Holders

Symbol
KLRS
CUSIP
482929106
Type
Equity
Class
COM
Num filings
56
Total reported value, excl. options
$73.4 M
Manager Report Date Value ($000) Shares Option Type